In biotechnology, the rank and file are well-to-do.
Many of the highest-paying employers in the health-care sector—and the entire S&P 500—were biotech companies, according to an analysis by The Wall Street Journal of annual disclosures for hundreds of big U.S. companies as provided by MyLogIQ.
New Jersey-based Celgene Corp. , which sells a treatment of multiple myeloma, had the highest-paid median employee in the sector and S&P 500 at $263,237. Celgene was followed by Boston-based Vertex Pharmaceuticals Inc., VRTX 1.61% which makes treatments for cystic fibrosis and infectious diseases, paying its typical worker $232,178.
Boards have been steadily reinforcing their ranks through the addition of more directors with military…
Governance Professionals Caution Against Knee-Jerk Reactions to Shifting Political Winds Meta Platforms added Dana White,…
Where CEO pay climbed and performance sank last year Danaher and United Parcel Service were…
As artificial intelligence grows more accessible, boards may have no choice but to embrace it…
A look at the demographics and skills of S&P 500 directors. Corporate boards have greater…
Companies with independent directors who've served on the board for more than 15 years are…